AR2-11227-17871
2 vaccinations
4 coded responses
20 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 105 / NY
- Registered
- 2022-07-02
- Relationship
- Child or adolescent in my care
- Guardian
- BFJ-81507-71092
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-01
Dose 1 — Moderna
-
2022-07-02
Registered in v-safe
-
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain, Redness · NoneUnder 3 check-in
- 2022-07-03
- 2022-07-04
- 2022-07-07
- 2022-07-08
- 2022-07-15
-
2022-07-27
Survey response — day 21, dose 1, under 3MedDRA: COVID-19, Cough, Lethargy, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid positive: fever, lethargy, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-07-29
Survey response — day 28, dose 1, under 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Diagnosed COVID-19MedDRA releases: 2024-11 · check-in free text available
-
2022-08-05
Dose 2 — Moderna
-
2022-08-07
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Swelling/hardness · NoneUnder 3 check-in
- 2022-08-08
- 2022-08-09
- 2022-08-10
- 2022-08-11
- 2022-08-14
-
2022-08-21
Survey response — day 14, dose 2, under 3MedDRA: Hand-foot-and-mouth disease — Feeling: GoodFree text: (b)(6) has contracted hand foot mouth virus.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-26
- 2022-09-02
- 2022-09-11
- 2022-09-16
-
2022-11-06
Survey response — 3 months, dose 2, under 3MedDRA: Conjunctivitis, Ear infection, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Ear infection. Pink eye. RSV.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-01 | Moderna | No |
| 2 | 2022-08-05 | Moderna | No |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Covid positive: fever, lethargy, cough
Release 12 (Under 3) — day 28, dose 1, under 3
Symptoms: Diagnosed COVID-19
Release 12 (Under 3) — day 14, dose 2, under 3
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Ear infection. Pink eye. RSV.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release